AgEngDawg
Legendary
- Joined
- Jan 9, 2021
- Messages
- 9,788
Lilly drug slows Alzheimer's progression by 35% in trial
In a phase 3 trial, donanemab slowed down the decline in patients' ability to think clearly and perform daily tasks by 35 percent compared to a placebo.
www.dailymail.co.uk